BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

  July 30, 2026

   · 

  13 min read
• Press Releases

  Actimed Therapeutics Strengthens Board with Appointment of Dr. Anders Ullman

  July 30, 2026

   · 

  3 min read
• Press Releases

  Relation Announces Expanded Collaboration with GSK

  July 30, 2026

   · 

  2 min read
• Press Releases

  NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC

  July 30, 2026

   · 

  6 min read
• Press Releases

  Amneal Reports Second Quarter 2026 Financial Results

  July 30, 2026

   · 

  36 min read
• Press Releases

  Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

  July 30, 2026

   · 

  7 min read
• Press Releases

  TIXiMED Appoints Stephen Daly and Albert R. Collinson, Ph.D., to Board of Directors

  July 30, 2026

   · 

  2 min read
• Press Releases

  Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

  July 30, 2026

   · 

  13 min read
• Press Releases

  Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors

  July 30, 2026

   · 

  6 min read
• Press Releases

  Regeneron Reports Second Quarter 2026 Financial and Operating Results

  July 30, 2026

   · 

  28 min read